CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 83 enrolled
Drug / intervention
Acupressure expectancy enhancementbehavioral
Likely dose
Not stated in record
Key inclusion· 5
  • ✓Diagnosis of breast cancer
  • ✓Scheduled to receive chemotherapy containing doxorubicin (any dose) without concurrent radiotherapy or interferon
  • ✓Age 18 years or older
  • ✓Chemotherapy naïve
Key exclusion· 1
  • ✕Clinical evidence of lymphedema, current bowel obstruction, or symptomatic brain metastases

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00243269
NCT00243269Phase 2Completed
CompareCT.gov

Acupressure and Relaxation for Nausea Control

University of Rochester·interventional·Posted Oct 21, 2005·Updated Jun 18, 2015

In Brief

A Phase 2 clinical trial evaluating Acupressure expectancy enhancement for Nausea. Completed, enrolled 83 participants across 1 site.

Detailed Summary

This study hypothesizes that patients receiving efficacy enhancing information about the acupressure bands will expect less treatment-related nausea, which will subsequently result in less treatment-related nausea compared to patients who do not receive such information. This study extends prior research by utilizing a randomized controlled trial in a clinical environment to examine the efficacy of an intervention that is specifically designed to reduce patients' response expectancies concerning nausea development from cancer treatments, and, thereby, reduce nausea. The objectives of this study are as follow: 1. To provide preliminary data on whether a two-tiered strategy to increase patients' expectancies for nausea prevention and/or management will result in reduced chemotherapy-induced nausea. 2. To provide preliminary data on whether a two-tiered strategy to increase patients' expectancies for nausea prevention and/or management will result in increased health-related quality of life (HRQL) in patients receiving emetogenic chemotherapy. To provide preliminary data on whether a two-tiered strategy to increase patients' expectancies for nausea prevention and/or management is more effective than a single-tiered strategy in reducing chemotherapy- induced nausea.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNausea
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 21, 2005
Enrollment StartNov 1, 2005
Primary CompletionMay 1, 2009
Study CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 20.7 years ago

Interventions

Acupressure expectancy enhancementbehavioral

This study hypothesizes that patients receiving efficacy enhancing information about the acupressure bands will expect less treatment-related nausea, which will subsequently result in less treatment-related nausea compared to patients who do not receive such information. This study extends prior research by utilizing a randomized controlled trial in a clinical environment to examine the efficacy of an intervention that is specifically designed to reduce patients' response expectancies concerning nausea development from cancer treatments, and, thereby, reduce nausea.